Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2003
07/10/2003WO2003055909A1 Regulation of human fatty acid binding protein
07/10/2003WO2003055908A2 Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases
07/10/2003WO2003055907A1 Tumour peptide antigen derived from the human cd19 protein
07/10/2003WO2003055906A1 Modified bacterial surface layer proteins
07/10/2003WO2003055905A2 Proteins of non typable haemophilus influenzae
07/10/2003WO2003055904A2 Peptidyl-trna hydrolase from pseudomonas aeruginosa
07/10/2003WO2003055903A1 Transcription regulatory gene and peptide
07/10/2003WO2003055901A1 Novel peptide sy
07/10/2003WO2003055899A2 Oxidized fungal antigens and methods of making and using thereof
07/10/2003WO2003055511A1 Liquid composition of modified factor vii polypeptides
07/10/2003WO2003055506A1 Preventives/remedies for cancer
07/10/2003WO2003055505A2 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders
07/10/2003WO2003055440A2 Compositions and methods for the treatement of immune related diseases
07/10/2003WO2003055439A2 Her2/neu target antigen and use of same to stimulate an immune response
07/10/2003WO2003038402A3 A peptide-based fluorescence polarization assay for detection of antibodies to mycobacterium bovis
07/10/2003WO2003033677A3 Dimerized growth factor and materials and methods for producing it
07/10/2003WO2003024992A3 HUMAN AND MOUSE β-DEFENSINS, ANTIMICROBIAL PEPTIDES
07/10/2003WO2003007880A3 Inhibition of behab cleavage and primary central nervous system (cns) tumors
07/10/2003WO2003004524A3 Apicomplexa parasites secreted proteins
07/10/2003WO2003002749A3 Methods for the simultaneous detection of hcv antigens and hcv antibodies
07/10/2003WO2003000861A3 Eukaryotic genes involved in adult lifespan regulation
07/10/2003WO2002102412A3 Selective inhibition of intracellular amyloid-beta neurotoxicity in human neurons
07/10/2003WO2002096937A3 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
07/10/2003WO2002092625A3 Moraxella(branhamella) catarrhalis antigens
07/10/2003WO2002090520A3 Toll/interleukin-1 receptor adaptor protein (tirap)
07/10/2003WO2002089728A3 Recombinant rhabdoviruses as live-viral vaccines
07/10/2003WO2002081502A3 Methods of crystal optimisation
07/10/2003WO2002079394A3 Synthesis and use of glycodendrimer reagents
07/10/2003WO2002074956A3 Dopaminergic neuronal survival-promoting factors and uses thereof
07/10/2003WO2002072788A3 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses
07/10/2003WO2002063008A3 Intracellular signaling molecules
07/10/2003WO2002059267A3 Constitutively desensitized g protein-coupled receptors
07/10/2003WO2002057310A3 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
07/10/2003WO2002046409A3 Proteins and nucleic acids encoding same
07/10/2003WO2002046238A3 Rationally designed antibodies
07/10/2003WO2002046229A3 Novel proteins and nucleic acids encoding same
07/10/2003WO2002042463A3 Compositions and methods relating to prostate specific genes and proteins
07/10/2003WO2002040672A3 Compositions and methods relating to breast specific genes and proteins
07/10/2003WO2002040541A3 Transporters and ion channels
07/10/2003WO2002040538A8 Regulation of human nmda receptor
07/10/2003WO2002038764A3 Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage
07/10/2003WO2002036766A3 Protein-protein complexes and methods of using same
07/10/2003WO2002034946A3 Cotton event pv-ghgt07(1445) and compositions and methods for detection thereof
07/10/2003WO2002032939A3 Secreted proteins and their uses
07/10/2003WO2002028408A9 Compositions and methods for the transport of biologically active agents across cellular barriers
07/10/2003WO2002024896A3 Screening assays for agonists or antagonists of receptor activat or of nf-kb
07/10/2003WO2002022675A3 Plant genes, the expression of which are altered by pathogen infection
07/10/2003WO2002018581A3 G-protein coupled receptors
07/10/2003WO2002018577A9 48921, a novel human gtp releasing factor and uses therefor
07/10/2003WO2002013845A3 Inflammation related g-protein coupled receptor
07/10/2003WO2002012281A3 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
07/10/2003WO2002006531A3 Nucleic acid hairpin probes and uses thereof
07/10/2003WO2002000730A9 Pd-l2 molecules: novel pd-1 ligands and uses therefor
07/10/2003WO2001096523A3 Polynucleotides related to colon cancer
07/10/2003WO2001089550A3 Use of ciliary neurotrophic factor
07/10/2003WO2001089549A3 Therapeutic uses of il-1 receptor antagonist
07/10/2003WO2001089364A9 Hcv variants
07/10/2003WO2001079556A3 Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers
07/10/2003WO2001068857A9 18615 and 48003, human ion channels and uses therefor
07/10/2003US20030131386 Stress-induced polynucleotides
07/10/2003US20030131384 Generating transgenic plants; controlling tumor protein
07/10/2003US20030131383 Peptides with enhanced stability to protease degradation
07/10/2003US20030131381 Novel ecdysone receptors and methods for their use
07/10/2003US20030131378 Binding toxin to insects; prevent insect resistance
07/10/2003US20030131377 DNA molecules from maize and methods of use thereof
07/10/2003US20030131375 Genetic engineering; hybrid plant cell
07/10/2003US20030131374 Pepper gene promoters; drives gene expression in transgenic plants
07/10/2003US20030131369 Metabotropic glutamate receptor 4B (mGluR4) disruptions, compositions and methods relating thereto
07/10/2003US20030131368 KV1.7 potassium channel disruptions, compositions and methods relating thereto
07/10/2003US20030131367 Kv3.3b potassium channel disruptions, compositions and methods related thereto
07/10/2003US20030131366 Non-human mammals comprising cells expressing vector-borne mouse PTTG carboxy-terminal-related DNA
07/10/2003US20030130797 Protein modeling tools
07/10/2003US20030130498 Highly infectious rubella virus DNA constructs and methods of production
07/10/2003US20030130496 Immunoglobulins; cloning, amplifying and encoding by DNA sequences, polymerase chain reaction
07/10/2003US20030130495 G-protein coupled receptors, signal transduction pathways
07/10/2003US20030130494 Mammalian chemokine reagents
07/10/2003US20030130493 Endothelial Differentiation Gene (Edg), neuroregulators, phospholipid metabolism, nervous systems
07/10/2003US20030130492 A purified polynucleotide encoding polypeptides for detecting, diagnosing, monitoring, preventing or treating breast cancer; genetic engineering
07/10/2003US20030130491 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130490 Genetic engineered protein drugs, such as thrombolytic agents, interferons, interleukins, erythropoietins; extracellular
07/10/2003US20030130489 Genetic engineered protein drugs, such as thrombolytic agents, interferons, interleukins, erythropoietins
07/10/2003US20030130487 Acellular red blood cell substitute
07/10/2003US20030130486 A fusion proteins having the C-terminal region of the interfero protein is replaced by a C-terminal region of tau proteins; viricides, antiproliferation agents, antiinflammatory agents; lower cytotoxic side effects
07/10/2003US20030130485 Novel human genes and methods of use thereof
07/10/2003US20030130484 A peptides for treating amyloid fibrils; drug screening for potential antagonist; antifibrillatory agents
07/10/2003US20030130483 Amino acid sequences free of signal peptide, encoded by cDNA; fusion proteins
07/10/2003US20030130219 Classification of genes; medical diagnosis
07/10/2003US20030130218 Methods of stimulating phagocytosis
07/10/2003US20030130215 Isolated genomic polynucleotide fragments from chromosome 7
07/10/2003US20030130214 Proteins, compositions, diagnostic and therapeutic uses thereof
07/10/2003US20030130197 Neuroprotective peptides
07/10/2003US20030130193 Controlling cell proliferation, cell differentiation; immobilization
07/10/2003US20030130187 Porcine adenovirus type 3 genome
07/10/2003US20030130186 Conjugates and compositions for cellular delivery
07/10/2003US20030130185 Metal-binding compounds and uses therefor
07/10/2003US20030130184 Using protein from papilloma virus; genetic engineering
07/10/2003US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130181 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130166 Polynucleotide encoding a human junctional adhesion protein (JAM2)
07/10/2003US20030129752 MEKK/JNKK-contingent (mitogen extracellular signal regulated kinases (MEKK), Jun N-terminal kinase) signal transduction pathway; tumor necrosis factor; interleukins
1 ... 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 ... 2916